Bulletins
Research Education Day June 22nd, 2012 - 9th Annual
Oncology Research & Education Day is organized by the CIHR-Strategic Training Program in Cancer Research and Technology Transfer (CaRTT) and the Department of Oncology at Western University. |
The 9th Annual Oncology Research & Education Day is an all-day event held at: This annual event is an opportunity for scientists, clinicians, graduate students and Post-Doctoral fellows to share cancer research discoveries and promote cancer research collaboration and training.
|
 |
 |
2012 Smith Errington Lecturer
It is a pleasure to announce that Dr. Shoukat Dedhar will be our keynote speaker for this year's event. His talk will be entitled: " Translational Cancer Research: A Tale of Two Targets"
|
Dr Dedhar received his BSc(Hons) in Biochemistry from the University in Aberdeen, Scotland, and his PhD from the University of British Columbia (UBC), Vancouver, Canada in 1984. He carried out a Postdoctoral Fellowship in the laboratory of Dr. Erkki Ruoslahti at the Burnham Institute (formerly, La Jolla Cancer Research Center). He then became an Assistant Professor in the Department of Pathology, at UBC, and a Scientist at the BC Cancer Agency. After three years he joined the Cancer Biology group at the Sunnybrook Health Sciences Center in Toronto, and in 1995 was promoted to Full Professor in the Department of Medical Biophysics, University of Toronto. In 1997, he returned to Vancouver as a Senior Scientist at the BC Cancer Agency and Full Professor in the Department of Biochemistry and Molecular Biology at UBC.
Dr Dedhar is a Distinguished Scholar of the Michael Smith Foundation for Health Research (MSFHR) ( 2001), and the recipient of the Terry Fox Cancer Research Scientist award of the NCIC.
Dr Dedhar has pioneered a large body of work in cell-extracellular matrix interactions in cancer. He is the discoverer of Integrin-Linked Kinase (ILK) which is an essential protein involved in the regulation of Integrin function and Integrin-mediated signal transduction. ILK deregulation plays a major role in cancer progression, kidney disease, cardiovascular disease, inflammatory diseases, myelination disorders, and neurodegeneration, and ILK is currently under investigation as a therapeutic target for these diseases.
Dr Dedhar’s more recent work has involved establishing novel mouse models of cancer metastasis. These models have led to significant insights into the roles of tumor microenvironment and hypoxic stress as driving forces for metastatic potential. These studies have also identified targets, such as carbonic anhydrase IX and XII, VEGF-C and pyruvate dehydrogenase kinase for cancer therapeutics targeting the metastatic process.
Dr Dedhar is Co-Founder of MetaSignal Therapeutics ( www.metasignal.ca), a Biotechnology company developing novel therapeutics targeting Tumor Hypoxia and Metabolism.
Dr. Dedhar is an author of 179 peer- reviewed papers and review articles, and an inventor on several patents.
ABSTRACT SUBMISSION & REGISTRATION
DEADLINE |
LINK |
|
| ABSTRACTS | Thursday, April 26, 2012 - NOON |
|
| REGISTRATION | Friday June 15, 2012 - NOON |
REGISTRATION CLOSED |
POSTER PRESENTATION INFORMATION
All posters MUST be posted prior to the beginning of the event, which begins promptly at 8am. Posters will be affixed to the boards using sticky velcro tabs that will be provided on the day of the event. You will be assigned a poster number which will denote the location of your poster. New Posters must be no larger than 4ft x 4ft. If your poster was used for a previous event and is larger, please indicate this with your submission.
ORAL PRESENTATION INFORMATION
Abstracts that are chosen for oral presentation will be data rich, and at a professional level. Those selected for oral presentation will be asked to upload their PowerPoint presentation by noon, Friday, June 15th, 2012. Detailed instructions will follow. This will allow the AV professional to identify potential problems with images, movies, etc. prior to the event. A laser pointer will be provided. The session Moderator will keep all speakers on time (10 minute talk + 5 minutes for questions).
If you are not a member of the Department of Oncology or the CIHR-STP and are interested in participating, please contact
Joanne Gribbon.
Gabe DiMattia, PhD
Eric Winquist, MD
David Palma, PhD
David Litchfield, PhD
Lina Dagnino, PhD
Jim Koropatnick, PhD
Slav Yartsev, PhD
Joanne Gribbon
The Lamplighter Inn is located at 591 Wellington Road South in London, Ontario.
For our event, the Crystal Ballroom will be separated into north and south halves with the north section for the oral presentations and the south section for food & beverages and poster presentations. Parking is free.
Award Winners
Also from this web page:
Upcoming Seminar:
|
10th Annual CaRTT Retreat
|
Accessibility at Western |
